Enliven Therapeutics, Inc. - Common Stock (ELVN)

CUSIP: 29337E102

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 6 signals
Share change
-77,951
SEC-reported price per share
$13.84
Number of holders
61
Value change
-$652,659
Number of buys
29
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
73,332,127

Security key

29337E102

Report period

Q4 2023

Institutions

61

Top holders

10

Ownership snapshot

Top reported holders of ELVN - Enliven Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
David P. Bonita
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $122,917,297 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $122.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
David P. Bonita $63.55M
Commodore Capital LP $39.64M
New Enterprise Associates 14, L.P. $39.52M
RA CAPITAL MANAGEMENT, L.P. $32.12M
Braden M. Leonard $30.24M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
David P. Bonita
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$63,552,894
4,207,568 shares
mixed-class rows
— 02 Jun 2022
Commodore Capital LP
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$39,638,807
2,901,816 shares
— 30 Sep 2023
New Enterprise Associates 14, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$39,518,242
2,611,050 shares
— 05 Apr 2022
RA CAPITAL MANAGEMENT, L.P.
3/4/5 13F
Former 10% owner · Company
—
denominator unverified
$32,123,508
2,122,465 shares
— 23 Feb 2023
Braden M. Leonard
3/4/5
10%+ Owner
—
denominator unverified
$30,236,309
1,997,774 shares
— 03 Jan 2023
Andrew J. Schwab
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
27,567 shares
— 23 Feb 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
61
Shares
39,000,634
Rows available
61
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
60
Q4 2023 holders
61
Holder diff
1
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .